In a mouse xenograft model, DLGAP5 knockdown significantly reduced 18F fluoro-D-deoxyglucose (18F-FDG) uptake which accurately reflects the level of glucose metabolism in tumor tissues and inhibited tumor growth (Figure 2F-G). The gene discussed is DLGAP5; the disease is neoplasm.